摘要
Abstract
Objective To analyze the pathogenic inspection submission of hospitalized patients with therapeutic use of anti-bacterial drugs and to provide reference for improving the pathogenic inspection rate of the patients.Methods The pathogenic in-spection of patients using antibiotics for systemic treatment in a general hospital from 1st January 2021 to 31st December 2022 was analyzed retrospectively,and the pathogenic inspection rates of different stages,different pathogenic specimens and different grades of antibiotics were compared.Results In 2022,the pathogenic inspection rates of before the antimicrobial treatment,af-ter the treatment and during the hospitalization were 35.23％,26.75％,and 61.98％,respectively,which were significantly higher than those in 2021(P＜0.001).In 2022,the pathogenic inspection rate of PCT was 52.04％,which was significantly higher than that in 2021(x2=194.139,P＜0.001).The rate of blood culture was 30.58％,significantly lower than that in 2021(x2=12.568,P＜0.001).Before the treatment of restricted and special antimicrobial drugs in 2022,the pathogenic in-spection rates were 41.96％and 84.32％,respectively,which were significantly higher than those in 2021(P＜0.05).Conclu-sion The pathogenic sample inspection rate of hospitalized patients has been improved before the treatment of antibiotics,but the inspection timing and structure of samples still need to be improved,and the rate of microorganism culture and drug sensitivity tests should be improved.关键词
住院患者/抗菌药物/病原学标本/送检率Key words
inpatient/antibacterial drug/pathogenic sample/inspection rate分类
医药卫生
